Atachi Systems Pledges Free MES software for 50 Small Medical Devices & Diagnostics, Pharma and Life Sciences Manufacturers.

January 08 14:00 2021
Atachi Systems would like to join the community in helping the small and medium manufacturers by providing Next Generation Manufacturing Execution Systems (NGIMES) software for the next 12 months for free.

San Jose – Jan 8, 2021 – NGIMES is the “premiere” MES for pharmaceutical manufacturing companies that use SAP ERP. It helps comply with 21CFR Part 11 electronic signatures, FDA audits, validation and confirms to US FDA cGMP requirements. Furthermore, pharmaceutical companies can take advantage of the cloud based MES (NGIMES) to contain costs while delivering accelerated performance with its in-memory computing platform.

Atachi Systems is pledging to give the NGIMES – Next Gen MES software (SAP Certified for being built on SAP Cloud Platform) running in the cloud FREE for the next 12 months for the first 50 small and mid-size manufacturers.

Due to Coronavirus epidemic, a new medical urgency has emerged now, and the disease burden of the world has increased manifold. To fight against this, it will be essential for pharmaceutical companies to develop effective new medicines to address the demands of the whole world at a faster pace than ever. Pharmaceutical and Medical Device Manufacturers are working very hard to produce the drugs and medical supplies, the demand for which is much higher than ever anticipated, that can provide the relief for the humanity at this time.

It is critical time for the humanity to fight against this epidemic and for this the Pharma manufacturers will have to collaborate with numerous service providers to deliver packages of care.

The fact that governments and health insurers everywhere are struggling to contain their expenditure. The issue is further exacerbated by the current economic turmoil that will put even greater financial pressure on the payer community. All the governments and businesses across the world have joined in funding the efforts to overcome this crisis.  

Atachi Systems would like to join hands with the community in helping the small and medium manufacturers in producing the medical supplies or devices and drugs in a compliant manner by giving the Next Generation Manufacturing Execution Systems (NGIMES), software for the next 12 months for free without any strings attached to continue the software afterwards. For speeding up manufacturing the drugs and medical devices and diagnostics and delivering it to the market.

“We take pride in honouring Atachi Systems as one among the 10 MES companies that are specialized in providing Pharmaceutical Manufacturing solutions,” said Stacey Smith, Managing Editor of Pharma Tech Outlook.

The cloud-based NGIMES platform offers a quality user experience, allowing effectively manage manufacturing operations using a single unified system. End-to-end supply chain and production visibility enables one to stay on top of every material movement and changes in production data across the enterprise.

NGIMES offers seamless setup and does not require investments in additional servers or IT maintenance. It’s highly flexible to serve complex manufacturing companies of all sizes without disrupting existing infrastructure. Integration is seamless with other applications, either on the cloud or on the premises.

About Atachi Systems:

Atachi Systems provides manufacturing companies with a seamless, cloud-based Manufacturing Execution System that reduces dependencies on infrastructure, lowers maintenance costs, and improves access to real-time visibility of shop-floor operations for engineers and managers at all levels. The company was founded in 2007 to streamline the MES solutions that enable discrete and continuous manufacturing companies to improve efficiency and grow profits. For more info, visit:

Media Contact
Company Name: Atachi Systems
Contact Person: Mekala Rao
Email: Send Email
Phone: (408)-839-1743
Address:2033 Gateway Place, 5th Floor
City: San Jose
State: California, 95110
Country: United States

view more articles

About Article Author